Barbara Schraml,
LMU Munich Biomedical Center,
Walter Brendel Center for Experimental Medicine

Title: Dendritic cells in early life. Immune sentinels wise beyond their age?

Barbara Schraml’s research focuses on understanding the precise organ-specific functions of dendritic cells in immunity and in the context of their local tissue environment.

Hans AR Bluyssen,
Department of Human Molecular Genetics,
Lab. of High Throughput Technologies,
Adam Mickiewicz University Poznan

Title: The multiple roles of STAT1 in IFN signaling and vascular inflammation: Towards diagnostic potential and therapeutic target.

Hans Bluyssen’ group aims at genome-wide and mechanistic understanding of the STAT- and IRF-dependent signal integration between TLR4 and IFNs (Type I and II) in vascular and immune cells in culture, and in experimental and clinical atherosclerosis.

Luka Cicin-Sain,
HZI Helmholtz Center for Infection Research,

Title: It takes two to tango: the immune system and the CMV

Luka Cicin-Sain‘s research group studies ubiquitous viruses that are persist for life in most people worldwide. In particular, our focus is on herpesviruses, whose persistence during latent infection shapes the immune system and its functionality.

Michael Sixt,
Institute of Science and Technology (IST)

Title: How leukocytes navigate through tissues

Michael Sixt's laboratory is interested in morphodynamic processes both at the cellular and at the tissue level. They focus on the immune system and try to understand the molecular and mechanical principles underlying leukocyte dynamics during processes such as migration and intercellular communication.


Christoph Binder,
Department of Laboratory Medicine MedUni Vienna,
Center for Molecular Medicine (CeMM), Austrian Academy of Sciences

Title: Oxidation-specific epitopes act as danger-associated molecular pattern in chronic inflammation

Christoph Binder is interested in the immune mechanisms of atherosclerosis and the immune recognition of oxidation-specific epitopes, and particularly how these responses can be exploited to protect from atherosclerotic lesion formation.


Andreas Pichlmair,
Institute of Virology,
TU Munich

Title: Organization of intracellular defense mechanisms and disturbance by viruses;

Andreas Pichlmair’s group is interested in understanding interactions between pathogenic viruses and their hosts on molecular and functional level, focusing on RNA-protein and protein-protein interactions.


Wilfried Ellmeier,
Division of Immunobiology,
Institute of Immunology, MedUni Vienna;
Coordinator of newly granted SFB F70 ‘HDACs as regulators of T cell-mediated immunity in health and disease’

Title: Histone deacetylases and the control of CD4+ T cell-mediated immunity

The long-term research interest of Wilfried Ellmeier’s group is to characterize molecular mechanisms that regulate the development and function of T lymphocytes. They aim to provide important and medical relevant insight into the regulation of T cell-mediated immunity.